Spectaire Holdings Inc. - Quarter Report: 2023 June (Form 10-Q)
☒ | QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
98-1578608 | |
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant |
PCCTU |
The Nasdaq Stock Market | ||
Class A ordinary shares, par value $0.0001 per share |
PCCT |
The Nasdaq Stock Market | ||
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 |
PCCTW |
The Nasdaq Stock Market |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
PERCEPTION CAPITAL CORP. II
TABLE OF CONTENTS
June 30, 2023 (Unaudited) |
December 31, 2022 |
|||||||
Assets: |
||||||||
Current assets: |
||||||||
Cash |
$ | 84,000 | $ | 4,730 | ||||
Prepaid expenses |
145,330 | 107,179 | ||||||
|
|
|
|
|||||
Total current assets |
229,330 | 111,909 | ||||||
Investments held in Trust Account |
22,585,023 | 25,517,987 | ||||||
|
|
|
|
|||||
Total Assets |
$ |
22,814,353 |
$ |
25,629,896 |
||||
|
|
|
|
|||||
Liabilities and Shareholders’ Deficit: |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 4,698,780 | $ | 783,055 | ||||
Accounts payable - related party |
15,023 | 104,808 | ||||||
Accrued expenses |
742,037 | 1,906,825 | ||||||
Accrued expense - related party |
12,181 | 10,977 | ||||||
Accrued offering costs |
224,235 | 224,235 | ||||||
Convertible promissory notes - related party |
1,742,552 | 221,631 | ||||||
Forward purchase units |
4,290,000 | — | ||||||
|
|
|
|
|||||
Total current liabilities |
11,724,808 | 3,251,531 | ||||||
Deferred underwriting fee payable |
5,635,000 | 8,050,000 | ||||||
|
|
|
|
|||||
Total Liabilities |
17,359,808 | 11,301,531 | ||||||
|
|
|
|
|||||
Commitments and Contingencies (Note 7) |
||||||||
Class A ordinary shares subject to possible redemption, 2,080,915 and 2,457,892 shares at redemption value of $10.81 and $10.34 per share at June 30, 2023 and December 31, 2022, respectively |
22,485,023 | 25,417,987 | ||||||
Shareholders’ Deficit: |
||||||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding |
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; no shares issued and outstanding at June 30, 2023 and December 31, 2022; excluding 2,080,915 and 2,457,892 shares subject to possible redemption, respectively , at June 30, 2023 and December 31, 2022 |
— | — | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 issued and outstanding |
575 | 575 | ||||||
Additional paid-in capital |
— | — | ||||||
Accumulated deficit |
(17,031,053 | ) | (11,090,197 | ) | ||||
|
|
|
|
|||||
Total shareholders’ deficit |
(17,030,478 | ) | (11,089,622 | ) | ||||
|
|
|
|
|||||
Total Liabilities and Shareholders’ Deficit |
$ |
22,814,353 |
$ |
25,629,896 |
||||
|
|
|
|
For the three months ended June 30, 2023 |
For the three months ended June 30, 2022 |
For the six months ended June 30, 2023 |
For the six months ended June 30, 2022 |
|||||||||||||
Operating and formation costs |
$ | 1,394,320 | $ | 373,599 | $ | 3,506,120 | $ | 881,975 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
(1,394,320 |
) |
(373,599 |
) |
(3,506,120 |
) |
(881,975 |
) | ||||||||
Interest and dividend income on investments held in Trust Account |
290,025 | 325,846 | 548,503 | 344,043 | ||||||||||||
Change in fair value of forward purchase units |
(270,000 | ) | — | (460,000 | ) | — | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net Loss |
$ |
(1,374,295 |
) |
$ |
(47,753 |
) |
$ |
(3,417,617 |
) |
$ |
(537,932 |
) | ||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted weighted average shares outstanding, Class A ordinary shares |
2,192,766 | 23,000,000 | 2,324,596 | 23,000,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net loss per share, Class A ordinary shares |
$ | (0.17 | ) | $ | 0.00 | $ | (0.42 | ) | $ | (0.02 | ) | |||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted weighted average shares outstanding, Class B ordinary shares |
5,750,000 | 5,750,000 | 5,750,000 | 5,750,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net loss per share, Class B ordinary shares |
$ | (0.17 | ) | $ | 0.00 | $ | (0.42 | ) | $ | (0.02 | ) | |||||
|
|
|
|
|
|
|
|
Class A ordinary shares |
Class B ordinary shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance - December 31, 2022 |
— |
$ |
— |
5,750,000 |
$ |
575 |
$ |
— |
$ |
(11,090,197 |
) |
$ |
(11,089,622 |
) | ||||||||||||||
Net loss |
— | — | — | — | — | (2,043,322 | ) | (2,043,322 | ) | |||||||||||||||||||
Remeasurement of Class A common stock to redemption amount |
— | — | — | — | — | (553,425 | ) | (553,425 | ) | |||||||||||||||||||
Initial measurement of forward purchase units |
— | — | — | — | — | (3,830,000 | ) | (3,830,000 | ) | |||||||||||||||||||
Reduction of deferred underwriting fee payable |
— | — | — | — | — | 2,415,000 | 2,415,000 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2023 |
— |
— |
5,750,000 |
575 |
— |
(15,101,944 |
) |
(15,101,369 |
) | |||||||||||||||||||
Net loss |
— | — | — | — | — | (1,374,295 | ) | (1,374,295 | ) | |||||||||||||||||||
Remeasurement of Class A common stock to redemption amount |
— | — | — | — | — | (554,814 | ) | (554,814 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - June 30, 2023 |
— |
$ |
— |
5,750,000 |
$ |
575 |
$ |
— |
$ |
(17,031,053 |
) |
$ |
(17,030,478 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A ordinary shares |
Class B ordinary shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance - December 31, 2021 |
— |
$ |
— |
5,750,000 |
$ |
575 |
$ |
— |
$ |
(7,196,643 |
) |
$ |
(7,196,068 |
) | ||||||||||||||
Net loss |
— | — | — | — | — | (490,179 | ) | (490,179 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2022 |
— |
— |
5,750,000 |
575 |
— |
(7,686,822 |
) |
(7,686,247 |
) | |||||||||||||||||||
Net loss |
— | — | — | — | — | (47,753 | ) | (47,753 | ) | |||||||||||||||||||
Remeasurement of Class A common stock to redemption amount |
— |
— |
— |
— |
— |
(246,790 | ) | (246,790 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - June 30, 2022 |
— |
$ |
— |
5,750,000 |
$ |
575 |
$ |
— |
$ |
(7,981,365 |
) |
$ |
(7,980,790 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the six months ended June 30, 2023 |
For the six months ended June 30, 2022 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net Loss |
$ | (3,417,617 | ) | $ | (537,932 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Interest and dividend income on investments held in Trust Account |
(548,503 | ) | (344,043 | ) | ||||
Change in fair value of forward purchase units |
460,000 | — | ||||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
(38,151 | ) | 147,519 | |||||
Accounts payable |
3,915,725 | (7,133 | ) | |||||
Accounts payable - related party |
(89,785 | ) | 52,921 | |||||
Accrued expenses |
(1,164,788 | ) | 280,210 | |||||
Accrued expenses - related party |
1,204 | — | ||||||
|
|
|
|
|||||
Net cash used in operating activities |
$ |
(881,915 |
) |
$ |
(408,458 |
) | ||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Advances to Trust Account |
(559,736 | ) | — | |||||
Proceeds from Trust Account for payment to redeeming shareholders |
4,041,203 | — |
||||||
|
|
|
|
|||||
Net cash provided by investing activities |
$ |
3,481,467 |
— |
|||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from convertible promissory notes - related party |
1,520,921 | — | ||||||
Payment to redeeming shareholders |
(4,041,203 | ) | ||||||
Payment of offering costs |
— | (7,000 | ) | |||||
|
|
|
|
|||||
Net cash used in financing activities |
(2,520,282 |
) |
(7,000 |
) | ||||
|
|
|
|
|||||
Net Change in Cash |
79,270 |
(415,458 |
) | |||||
Cash - Beginning of period |
4,730 | 818,833 | ||||||
|
|
|
|
|||||
Cash - End of period |
$ |
84,000 |
$ |
403,375 |
||||
|
|
|
|
|||||
Supplemental disclosures of non-cash investing and financing activities: |
||||||||
Accretion of Class A ordinary shares subject to redemption value |
$ | 1,108,239 | $ | 246,790 | ||||
Reduction of deferred underwriting fee payable |
$ | 2,415,000 | $ | — | ||||
Initial measurement of forward purchase units |
$ | 3,830,000 | $ | — |
Gross proceeds |
$ | 230,000,000 | ||
Less: |
||||
Proceeds allocated to Public Warrants |
(9,637,000 | ) | ||
Issuance costs allocated to Class A ordinary shares |
(12,907,420 | ) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
28,124,181 | |||
Initial Pre-Extension Redemption |
(210,161,774 | ) | ||
|
|
|||
Class A ordinary shares subject to possible redemption as of December 31, 2022 |
25,417,987 |
|||
Plus: |
||||
Remeasurement of carrying value to redemption value |
1,108,239 | |||
Initial Pre-Extension Redemption |
(4,041,203 | ) | ||
|
|
|||
Class A ordinary shares subject to possible redemption as of June 30, 2023 |
$ |
22,485,023 |
For the three months ended June 30, 2023 |
For the three months ended June 30, 2022 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net loss per share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Net loss |
$ | (379,403 | ) | $ | (994,892 | ) | $ | (38,202 | ) | $ | (9,551 | ) | ||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average shares |
2,192,766 | 5,750,000 | 23,000,000 | 5,750,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net loss per share |
$ |
(0.17 |
) |
$ |
(0.17 |
) |
$ |
0.00 |
$ |
0.00 |
||||||
|
|
|
|
|
|
|
|
For the six months ended June 30, 2023 |
For the six months ended June 30, 2022 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net loss per share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Net loss |
$ | (983,898 | ) | $ | (2,433,719 | ) | $ | (430,346 | ) | $ | (107,586 | ) | ||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average shares |
2,324,596 | 5,750,000 | 23,000,000 | 5,750,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net loss per share |
$ |
(0.42 |
) |
$ |
(0.42 |
) |
$ |
(0.02 |
) |
$ |
(0.02 |
) | ||||
|
|
|
|
|
|
|
|
June 30, 2023 |
December 31, 2022 |
|||||||
Accrued expenses: |
||||||||
Accrued legal fees |
$ | 300,592 | $ | 1,905,225 | ||||
Accrued printing costs related to S-4 filing |
432,245 | — | ||||||
Accrued accounting fees |
9,200 | 1,600 | ||||||
|
|
|
|
|||||
Total accrued expenses |
$ | 742,037 | $ | 1,906,825 | ||||
|
|
|
|
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the reported last reported sale price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share. |
Description |
Amount at Fair Value |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
June 30, 2023 (unaudited) |
||||||||||||||||
Assets |
||||||||||||||||
Investments held in Trust Account: |
||||||||||||||||
U.S. Treasury Securities |
$ | 22,585,023 | $ | 22,585,023 | $ | — | $ | — | ||||||||
Liabilities |
||||||||||||||||
Forward Purchase Units |
$ | 4,290,000 | $ | — | $ | — | $ | 4,290,000 | ||||||||
December 31, 2022 |
||||||||||||||||
Assets |
||||||||||||||||
Investments held in Trust Account: |
||||||||||||||||
U.S. Treasury Securities |
$ | 25,517,987 | $ | 25,517,987 | $ | — | $ | — |
At January 14, 2023 (inception) |
At June 30, 2023 |
|||||||
Equity value |
$ | 10.75 | $ | 11.20 | ||||
Strike Price |
$ | 11.93 | $ | 12.10 | ||||
Remaining Life (years) |
1.80 | 1.75 | ||||||
Risk-free rate |
4.70 | % | 5.40 | % | ||||
Volatility |
52.90 | % | 49.30 | % |
Level 3 |
||||
Fair value as of January 14, 2023 (inception) |
$ | 3,830,000 | ||
Change in fair value of Forward Purchase Agreement |
460,000 | |||
Fair value as of June 30, 2023 |
$ | 4,290,000 | ||
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Perception Capital Corp. II. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Perception Capital Partners II LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its initial public offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.report. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated as a Cayman Islands exempted company on January 21, 2021 formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We intend to effectuate our initial business combination using cash from the proceeds of our initial public offering and the sale of the private placement warrants, the proceeds of the sale of our shares in connection with our initial business combination pursuant to the forward purchase agreements (or backstop agreements we may enter into or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing or other sources.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities for the period from January 21, 2021 (inception) through June 30, 2023 were organizational activities, those necessary to prepare for our initial public offering described above, and, since the closing of our initial public offering, the search for a prospective initial business combination. We do not expect to generate any operating revenues until after the completion of our initial business combination. We will generate non-operating income in the form of interest income and dividends on investments held in our trust account after our initial public offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
25
For the three months ended June 30, 2023, we had a net loss of $1,374,295, which resulted from interest and dividend income on investments held in the in trust account of $290,025, offset by operating and formation costs of $1,394,320 and the change in fair value of forward purchase units of $270,000.
For the three months ended June 30, 2022, we had a net loss of $47,753, which resulted from interest and dividend income on investments held in the in trust account of $325,846, offset by operating and formation costs of $373,599.
For the six months ended June 30, 2023, we had a net loss of $3,417,617, which resulted from interest and dividend income on investments held in the in trust account of $548,503, offset by operating and formation costs of $3,506,120 and a loss on the change in fair value of forward purchase units of $460,000.
For the six months ended June 30, 2022, we had a net loss of $537,932, which resulted from interest and dividend income on investments held in the in trust account of $344,043, offset by operating and formation costs of $881,975.
Liquidity, Going Concern and Capital Resources
The registration statement for our initial public offering was declared effective on October 27, 2021. On November 1, 2021, we consummated our initial public offering of 23,000,000 units, (the “units” and, with respect to the Class A ordinary shares included in the units sold, the “public shares”), including 3,000,000 units issued pursuant to the exercise of the underwriters’ over-allotment option in full, generating gross proceeds of $230,000,000.
Simultaneously with the closing of our initial public offering, we consummated the sale of 10,050,000 warrants (the “private placement warrants”) at a price of $1.00 per private placement warrant in a private placement to Perception Capital Partners II LLC (the “sponsor”), including 1,050,000 private placement warrants issued pursuant to the exercise of the underwriters’ over-allotment option in full, generating gross proceeds of $10,050,000.
For the six months ended June 30, 2023, net cash used in operating activities was $881,915 which was due to the net loss of $3,417,617 and interest income on investments held in Trust Account of $548,503, offset in part by changes in working capital of $2,624,205 and an unrealized loss on the change in fair value of forward purchase units of $460,000.
For the six months ended June 30, 2022, net cash used in operating activities was $408,458, which was due to the net loss of $537,932 and interest income on investments held in Trust Account of $344,043, offset in part by changes in working capital of $473,517.
For the six months ended June 30, 2023, net cash provided by investing activities was $3,481,467, which was due to proceeds from Trust Account for payment to redeeming shareholders of $4,041,203 offset by advances into the trust account of $559,736.
For the six months ended June 30, 2022, there were no cash flows from investing activities.
For the six months ended June 30, 2023, net cash used in financing activities was $2,520,282, which was due to payment to redeeming shareholders of $4,041,203, offset by proceeds from convertible promissory notes - related party of $1,520,921.
For the six months ended June 30, 2022, net cash used in financing activities was $7,000, which was due to payments of offering costs of $7,000.
As of June 30, 2023, we had cash of $84,000 held outside the trust account. We intend to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.
26
Our liquidity will be satisfied through the proceeds made available to the Company under working capital loans, extension loans, and the Spectaire Loan. In addition, the non-interest bearing promissory note was repaid in full with the proceeds from the private placement.
During the year ended December 31, 2022, the sponsor exercised the extension option, depositing into the trust account $0.04 per share, monthly (a total of $196,631 in 2022 and an additional $726,209 in 2023), extending the deadline to complete our initial business combination to May 1, 2023, which subsequently in April 2023 was extended to November 1, 2023. If our initial business combination is not consummated by November 1, 2023, there will be a mandatory liquidation and subsequent dissolution of the Company. On January 16, 2023, we entered into an Agreement and Plan of Merger with Perception Spectaire Merger Sub Corp., a Delaware corporation and a direct wholly owned subsidiary of PCCT (“Merger Sub”), and Spectaire Inc., a Delaware corporation (“Spectaire”).
We have determined that, due to the mandatory liquidation and subsequent dissolution should our initial business combination or extension not occur by November 1, 2023, there is substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that these financial statements are issued. We plan to address this uncertainty through our initial business combination or extension as discussed above. There is no assurance that our plans to consummate an initial business combination or extension will be successful. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Off-Balance Sheet Arrangements
We did not have any off-balance sheet arrangements as of June 30, 2023.
Contractual Obligations
Registration and Shareholder Rights Agreement
The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement signed prior to the effective date of our initial public offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require that we register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that we will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. We will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
Simultaneously with our initial public offering, the underwriters fully exercised the over-allotment option to purchase an additional 3,000,000 units at an offering price of $10.00 per Unit for an aggregate purchase price of $30,000,000.
27
The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $4,600,000 in the aggregate, upon the closing of our initial public offering. In addition, $0.35 per unit, or $8,050,000 in the aggregate will be payable to the underwriters for deferred underwriting commissions.
The deferred fee will become payable to the underwriters from the amounts held in the trust account solely in the event that we complete a business combination, subject to the terms of the underwriting agreement. On March 23, 2023, the underwriters agreed to reduce the amount of such deferred underwriting discount from $8,050,000 to $5,635,000.
Critical Accounting Policies
The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
Net Loss Per Ordinary Share
Net loss per ordinary share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the period. Accretion associated with the redeemable Class A ordinary shares is excluded from net loss per share as the redemption value approximates fair value. Therefore, the earnings per share calculation allocates income and losses shared pro rata between Class A and Class B ordinary shares. As a result, the calculated net loss per share is the same for Class A and Class B ordinary shares. We have not considered the effect of the public warrants and private placement warrants to purchase an aggregate of 21,550,000 shares in the calculation of diluted net loss per share, since the exercise of the warrants are contingent upon the occurrence of future events.
Derivative Financial Instruments
We evaluate our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, Derivatives and Hedging. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Class A Ordinary Shares Subject to Possible Redemption
All of the 23,000,000 Class A ordinary shares sold as part of the units in our initial public offering contain a redemption feature which allows for the redemption of such public shares in connection with our liquidation, if there is a shareholder vote or tender offer in connection with our initial business combination and in connection with certain amendments to our amended and restated memorandum and articles of association. In accordance with ASC Topic 480, Distinguishing Liabilities from Equity (“ASC 480”), redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. Therefore, all public shares have been classified outside of permanent equity.
28
We recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in capital and accumulated deficit.
Fair Value of Forward Purchase Agreement
The Company applies fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. The Company uses judgment to select the methods used to make certain assumptions and in performing the fair value calculations in order to determine (a) the values attributed to each component of a transaction at the time of their issuance; (b) the fair value measurements for certain instruments that require subsequent measurement at fair value on a recurring basis; and (c) for disclosing the fair value of financial instruments. These valuation estimates could be significantly different because of the use of judgment and the inherent uncertainty in estimating the fair value of these instruments that are not quoted in an active market.
Recent Accounting Standards
Our management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
This item is not applicable as we are a smaller reporting company.
Item 4. Controls and Procedures.
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2023. Based upon his evaluation, our certifying officers concluded that, as of June 30, 2023, our disclosure controls and procedures were not effective due to a material weakness in our internal controls over financial reporting related to the recording of the change in fair value of forward purchase units during the preparation of our quarterly report on Form 10-Q as of and for the period ended June 30, 2023. In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with US GAAP. Management believes that the financial statements included in this report present fairly in all material respects our financial position, results of operations and cash flows for the period presented.
Changes in Internal Control Over Financial Reporting
During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
29
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us or any of our officers or directors in their corporate capacity.
ITEM 1A. RISK FACTORS
Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks included below or described in the Company’s annual report on Form 10-K as filed with the SEC on March 27, 2023. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. Except as described below, as of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in the Company’s annual report on Form 10-K as filed with the SEC on March 27, 2023.
Our search for a Business Combination, and any target business with which we may ultimately consummate a Business Combination, may be materially adversely affected by the geopolitical conditions resulting from the recent invasion of Ukraine by Russia and subsequent sanctions against Russia, Belarus and related individuals and entities and the status of debt and equity markets, as well as protectionist legislation in our target markets.
United States and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions and the recent invasion of Ukraine by Russia in February 2022. In response to such invasion, the North Atlantic Treaty Organization (“NATO”) deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication (SWIFT) payment system. Certain countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine during the ongoing military conflict, increasing geopolitical tensions with Russia. The invasion of Ukraine by Russia and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom, the European Union and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing military conflict in Ukraine is highly unpredictable, the conflict could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions. Additionally, Russian military actions and the resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets. In addition, the recent invasion of Ukraine by Russia, and the impact of sanctions against Russia and the potential for retaliatory acts from Russia, could result in increased cyber-attacks against U.S. companies.
Any of the above mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine and subsequent sanctions, could adversely affect our search for a Business Combination and any target business with which we may ultimately consummate a Business Combination. The extent and duration of the Russian invasion of Ukraine, resulting sanctions and any related market disruptions are impossible to predict, but could be substantial, particularly if current or new sanctions continue for an extended period of time or if geopolitical tensions result in expanded military operations on a global scale. Any such disruptions may also have the effect of heightening many of the other risks described in the “Risk Factors” section of our Annual Report on Form 10-K. If these disruptions or other matters of global concern continue for an extensive period of time, our ability to consummate a Business Combination, or the operations of a target business with which we may ultimately consummate a Business Combination, may be materially adversely affected.
30
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Unregistered Sales
Prior to our initial public offering, our sponsor, paid an aggregate of $25,000 to cover certain expenses on behalf of us in exchange for 5,750,000 founder shares, resulting in an effective purchase price paid for the founder shares of approximately $0.004 per share. The number of founder shares issued was determined based on the expectation that the founder shares would represent 20% of the issued and outstanding ordinary shares upon completion of this offering.
Our sponsor purchased 10,050,000 private placement warrants, each exercisable to purchase one ordinary share at $11.50 per share, at a price of $1.00 per warrant ($10,050,000 in the aggregate), in a private placement that closed substantially concurrently with the closing of our initial public offering.
These issuances were made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No underwriting discounts or commissions were paid with respect to such sales.
Use of Proceeds
On November 1, 2021, the Company consummated its initial public offering of 23,000,000 units at $10.00 per unit, generating gross proceeds of $230,000,000. Jefferies LLC, Moelis & Company LLC and Nomura Securities International, Inc. acted as the book-running managers of the offering and Jefferies LLC acted as the representative of the underwriters. The securities sold in our initial public offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-255107). The SEC declared the registration statements effective on October 27, 2021.
Our sponsor purchased 10,050,000 private placement warrants, each exercisable to purchase one ordinary share at $11.50 per share, at a price of $1.00 per warrant ($10,050,000 in the aggregate), in a private placement that closed substantially concurrently with the closing of our initial public offering.
In connection with our initial public offering, we incurred offering costs of approximately $13,507,794 (including deferred underwriting commissions of approximately $8,050,000). Other incurred offering costs consisted principally of preparation fees related to our initial public offering. After deducting the underwriting discounts and commissions (excluding the deferred portion, which amount will be payable upon consummation of the initial Business Combination, if consummated) and our initial public offering expenses $233,450,000 of the net proceeds from our initial public offering and certain of the proceeds from the private placement of the Private Placement Warrants (or $10.15 per unit sold in our initial public offering) was placed in the Trust Account. The net proceeds of our initial public offering and certain proceeds from the sale of the Private Placement Warrants are held in the Trust Account and invested as described elsewhere in this Quarterly Report on Form 10-Q.
There has been no material change in the planned use of the proceeds from our initial public offering and sale of private placement warrants as is described in the Company’s final prospectus related to our initial public offering as filed with the SEC on October 29, 2021.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
31
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
(a). None.
(b). None.
(c). During the three months ended June 30, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each such term is defined in Item 408(a) of Regulation S-K.
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
* | Filed herewith. |
** | Furnished. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Perception Capital Corp. II | ||||||
Date: August 22, 2023 | By: | /s/ Rick Gaenzle | ||||
Rick Gaenzle | ||||||
Chief Executive Officer | ||||||
Perception Capital Corp. II | ||||||
Date: August 22, 2023 | By: | /s/ Corey Campbell | ||||
Corey Campbell | ||||||
Chief Financial Officer |
32